文献速递胃肠外科围术期管理与 ERAS

法国外科协会多中心队列:老年胃癌患者的手术管理

Surgical Management of Gastric Cancer in Elderly Patients: Results of a Multicenter Cohort of the French Surgical Association.
PubMed 文献 · J Am Coll Surg · 2025-12-17

该多中心回顾性队列纳入2007至2017年法国1,426例胃癌手术患者,按年龄分为<70岁、70–79岁、≥80岁三组。高龄患者接受的新辅助化疗、全胃切除、D2淋巴结清扫及术后治疗均更少,医疗并发症随年龄增加,但高龄并非严重术后并发症的独立危险因素;五年的总生存率随年龄下降,而癌症特异性生存率保持稳定。

要点

  • 高龄不是严重术后并发症(Clavien-Dindo III级及以上)的独立危险因素。
  • 高龄患者接受的新辅助化疗、全胃切除、D2清扫及术后治疗均显著更少。
  • 癌症特异性生存率在各年龄组间保持稳定,但总生存率随年龄下降。

核心结论

  • 高龄不独立增加术后并发症风险,不应作为减少手术侵袭性的依据。
  • 经过筛选的高龄患者即使围术期治疗较少,癌症预后仍与年轻患者相当。

研究设计与样本

  • 法国外科协会多中心回顾性队列,2007–2017年共识别2,131例患者。
  • 排除转移性疾病、未行胃切除、急诊手术、腹腔热灌注化疗及出生日期不明者后,最终纳入1,426例。
  • 按年龄分组:<70岁(第1组,60%)、70–79岁(第2组,27%)、≥80岁(第3组,13%)。

主要发现

  • 高龄患者更多为女性,新辅助化疗比例随年龄降低(58% vs 43% vs 17%,p<0.001)。
  • 全胃切除比例随年龄降低(68% vs 55% vs 43%,p<0.001),D2清扫比例亦降低(22% vs 22% vs 12%,p=0.007)。
  • 医疗并发症随年龄增加,但第3组手术并发症未显著增高。
  • 术后治疗比例随年龄降低(67% vs 45% vs 16%,p<0.001)。
  • 五年总生存率随年龄下降(64% vs 52% vs 37%,p<0.001),癌症特异性生存率保持稳定(69% vs 67% vs 63%,p=0.56)。

关键数值与推荐

  • 严重术后并发症定义为Clavien-Dindo III级或以上,高龄并非其独立危险因素。
  • 病理结果在各年龄组间具有可比性。

临床怎么用

  • 对高龄胃癌患者不应仅因年龄而降低手术根治性,应基于生理状态和合并症进行个体化评估。
  • 高龄患者围术期治疗强度较低,但仍需关注其医疗并发症风险。

局限性

  • 本研究为回顾性队列设计,存在选择偏倚可能。
  • 仅纳入法国外科协会中心患者,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer primarily affects the elderly, but surgical management varies with age. This multicenter, retrospective cohort study assessed treatment approaches and outcomes in patients with gastric cancer based on age. STUDY DESIGN: Between 2007 and 2017, 2,131 patients treated in French Surgical Association centers were identified. Patients with metastatic disease, those who did not undergo gastrectomy, those who underwent emergency surgery, those who underwent hyperthermic intraperitoneal chemotherapy, and those with unspecified birth dates were excluded. The final cohort of 1,426 patients was divided into 3 age groups: younger than 70 years (group 1, 60%), 70 to 79 years (group 2, 27%), and 80 years or older (group 3, 13%). RESULTS: Elderly patients were more often women and received less neoadjuvant chemotherapy (58% vs 43% vs 17%, p < 0.001). Despite similar tumor locations, they underwent fewer total gastrectomies (68% vs 55% vs 43%, p < 0.001) and D2 dissections (22% vs 22% vs 12%, p = 0.007). Medical complications increased with age, whereas surgical complications were not significantly higher in group 3. Advanced age was not an independent risk factor for severe postoperative complications (Clavien-Dindo grade III or higher). Pathologic results were comparable, but elderly patients received less postoperative treatment (67% vs 45% vs 16%, p < 0.001). Five-year overall survival decreased with age (64% vs 52% vs 37%, p < 0.001), whereas cancer-specific survival remained stable (69% vs 67% vs 63%, p = 0.56). CONCLUSIONS: Advanced age does not independently increase the risk of postoperative morbidity and should not justify less aggressive surgery. Despite receiving less perioperative treatment, selected elderly patients maintain a comparable cancer prognosis to younger individuals.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Manceau G, Lambert C, Pereira B, et al. Surgical Management of Gastric Cancer in Elderly Patients: Results of a Multicenter Cohort of the French Surgical Association. J Am Coll Surg. 2025. PMID: 40772696. doi:10.1097/XCS.0000000000001564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。